DIVERSITY IN CLINICAL TRIALS GAINS GROUND AMIDST COVID
Applied Clinical Trials
; 30(1/2):4, 2021.
Artículo
en Inglés
| ProQuest Central | ID: covidwho-20244567
ABSTRACT
More recent policies aim to offset years of underenrollment of minority groups by expanding enrollment criteria, including more research sites in minority communities, and engaging investigators with diverse backgrounds. FDA has also sought to promote research diversity through its Drug Trials Snapshots program, established in 2015 to increase the visibility of clinical trial enrollment by age, sex, ethnicity and race. According to a recent report on the program's impact, though, there still may be a ways to go for clinical trials to reflect the diversity of the US population.
Buscar en Google
Colección:
Bases de datos de organismos internacionales
Base de datos:
ProQuest Central
Tipo de estudio:
Estudio experimental
/
Estudio pronóstico
/
Ensayo controlado aleatorizado
Idioma:
Inglés
Revista:
Applied Clinical Trials
Año:
2021
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS